Syndax management to participate in September investor conferences
Syndax Pharmaceuticals said CEO Michael A. Metzger and members of the management team will participate in September investor conferences.
NEW YORK, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals NASDAQ:SNDX, a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A.
Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate i…